Daiwa Securities Group Inc. - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11
-31.2%
5460.0%0.00%
Q2 2023$16
+23.1%
5460.0%0.00%
Q1 2023$13
-13.3%
5460.0%0.00%
Q4 2022$15
-99.9%
546
+19.2%
0.00%
Q3 2022$14,000
+7.7%
4580.0%0.00%
Q2 2022$13,000
+18.2%
458
+28.7%
0.00%
Q1 2022$11,000
-31.2%
3560.0%0.00%
Q4 2021$16,000
-23.8%
356
-14.6%
0.00%
Q3 2021$21,000
+10.5%
417
+73.8%
0.00%
Q2 2021$19,000
+35.7%
2400.0%0.00%
Q1 2021$14,000
-26.3%
240
+6.2%
0.00%
Q4 2020$19,000
-9.5%
226
-61.5%
0.00%
Q3 2020$21,000
+110.0%
5870.0%0.00%
Q2 2020$10,0000.0%5870.0%0.00%
Q1 2020$10,000
+11.1%
587
+8.3%
0.00%
Q4 2019$9,0000.0%542
-10.3%
0.00%
Q3 2019$9,000
-30.8%
6040.0%0.00%
Q2 2019$13,000
-7.1%
6040.0%0.00%
Q1 2019$14,000
-12.5%
604
-21.0%
0.00%
Q4 2018$16,0007650.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders